Optimized formulation of tobramycin for aerosolization

  • US 6,987,094 B2
  • Filed: 06/14/2002
  • Issued: 01/17/2006
  • Est. Priority Date: 07/02/2001
  • Status: Active Grant
First Claim
Patent Images

1. An aerosol formulation consisting of 75 mg/ml of tobramycin dissolved in an aqueous solution containing 0.45% sodium chloride;

  • wherein the pH is between 4.0 and 5.5 and the osmolarity ranges between 250 and 450 mOsm/l.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×